Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Lakartidningen|August 28, 2020
[Large health benefits can be achieved by better treatment of gout]Anna Svärd, Meliha Kapetanovic, Ulrika Bergsten, et al.
Lakartidningen|August 28, 2020
[Consequences of Gout and Hyperuricemia]Mats Dehlin, Meliha Kapetanovic, Anna Svärd, et al.
Lakartidningen|August 28, 2020
[Gout - a common and well known disease]Valgerdur Sigurdardottir, Anna Svärd, Kristina Bengtsson Boström, et al.
Plos One|February 3, 2017
EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registryTanja Schjødt Jørgensen, Carl Turesson, Meliha Kapetanovic, et al.
Microbiology Spectrum|March 5, 2024
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)Martina Frodlund, Per Nived, Katerina Chatzidionysiou, et al.
Journal of Patient Experience|July 29, 2025
Vaccine Knowledge and Awareness Among Patients With Chronic Inflammatory Diseases: Results From a Nordic SurveyMeliha Kapetanovic, Randeep Mandla, Susanne Thiesen Gren, et al.
Aging Clinical and Experimental Research|February 22, 2025
Musculoskeletal diseases, infections and vaccines: state of the art, research perspectives and educational needsFiona Ecarnot, Jotheeswaran Amuthavalli Thiyagarajan, Mario Barbagallo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With GoutNicholas A Sumpter, Riku Takei, Murray Cadzow, et al.
The Lancet. Rheumatology|March 25, 2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trialJon Lampa, Dan Nordström, Ronald van Vollenhoven, et al.
BMJ (Clinical Research Ed.)|December 3, 2020
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trialMerete Lund Hetland, Espen A Haavardsholm, Anna Rudin, et al.
Pageof 1